HIV protein switch may help virus squeeze into host cell nucleus
Supercomputer simulations have revealed how changes in the shape of the HIV-1 capsid protein may help the virus squeeze its ...
Utah Public Radio20h
A breakthrough HIV drug was developed using Utah biochemistry research
An HIV drug was named “2024 Breakthrough of the Year” by Science Magazine. Biochemistry research from the University of Utah ...
GlobalData on MSN17h
Gilead’s lenacapavir moves closer to FDA approval for HIV PrEP use
Lenacapavir is already approved under the name Sunlenca as an HIV treatment for patients resistant to other medication ...
Hosted on MSN2mon
Sangamo to receive $20M from Astellas Pharma in capsid license agreement
Astellas Pharma (ALPMY) and Sangamo (SGMO) announced they have entered into a license agreement allowing Astellas to leverage Sangamo’s neurotropic adeno-associated virus capsid, STAC-BBB ...
Hosted on MSN29d
How HIV cracks the lock to the cell nucleus
Ultimately, the virus uses our body's machinery to produce copies of itself and spread infection. The HIV-1 capsid is formed by a mesh of around 200 protein hexamers and pentamers, arranged ...